EP0000984B1 - Programmable pacer with variable amplifier gain - Google Patents
Programmable pacer with variable amplifier gain Download PDFInfo
- Publication number
- EP0000984B1 EP0000984B1 EP19780300237 EP78300237A EP0000984B1 EP 0000984 B1 EP0000984 B1 EP 0000984B1 EP 19780300237 EP19780300237 EP 19780300237 EP 78300237 A EP78300237 A EP 78300237A EP 0000984 B1 EP0000984 B1 EP 0000984B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- pacemaker
- signals
- heart
- input amplifier
- signal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102100026827 Protein associated with UVRAG as autophagy enhancer Human genes 0.000 title 1
- 101710102978 Protein associated with UVRAG as autophagy enhancer Proteins 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 claims description 11
- 230000006870 function Effects 0.000 claims description 8
- 230000000747 cardiac effect Effects 0.000 claims description 7
- 230000005669 field effect Effects 0.000 claims description 5
- 239000003990 capacitor Substances 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 230000003321 amplification Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
Definitions
- This invention relates to cardiac pacemakers.
- Pacemakers for generating artificial stimulating pulses for the heart, and which may be implanted in the body, are well known.
- the electrical circuitry for such pacemakers was of analog design, but in recent years digital circuitry has been also employed.
- a digital approach to pacemakers has led to the evolution of programmable pacemakers-pacemakers having parameters such as pulse rates which are adjustable (programmable) once the pacemaker has been implanted.
- the programs can be changed from outside the patient's body by appropriate signal transmission to the implanted pacemaker and without surgery.
- Programmable pacemakers are described in for instance, British Specifications 1,385,954 and 1,398,875.
- Such pacemakers have circuitry to detect and decode signals transmitted outside the body and alter the program accordingly.
- pacemakers are of the demand type- that is they only supply a stimulating pulse to the heart when a natural heart beat is absent. To accomplish this, demand pacemakers have means for sensing the presence or absence of natural heat beats and for actuating the stimulating pulse as appropriate.
- Demand pacemakers normally have an input amplifier which receives the electrical signals detected at the heart, and the amplified signals are then employed to control the demand function of the pacemaker.
- signals provided by the input amplifier are employed to inhibit any artificial pulse being generated by the pacemaker: the absence of such signals being taken by the pacemaker as indicating the absence of a normal heart beat and causing artificial stimulating pulses to be generated.
- Pacemakers are implanted in the body for a period of years, and during that time various parameters can change causing the effective signals supplied by the input amplifier to change in magnitude. Typical of such parameters is an increase in impedance of the body tissue as "seen" by the pacing electrode. But most prevalent is the wide range of electrode placement effectiveness which can result in not only very large but very small signals.
- U.S. Patent 4,049,004 describes an implantable cardiac pacemaker with a number of externally programmable pacemaker functions including the sensitivity of the pacemaker response to signals at the heart.
- the pacemaker includes an R-wave input amplifier constructed as an operational amplifier whose output is employed for resetting the stimulating pulse generator, thereby giving the pacemaker a demand capability.
- the output of the operational amplifier is supplied to a field effect transistor whose switching threshold is varied from a master parameter control.
- the latter is a memory store whose contents may be varied after implantation from a remote source of programming signals. This arrangement has no effect on the overall amplification provided to the signal supplied to the R-wave amplifier and can cause erroneous control of the pacemaker in certain operational states.
- the field effect transistor can cut off the signal which should be employed to reset the pulse generator.
- a pacemaker circuit which enables the signal supplied by the input amplifier to be changed after implantation and which does enable, for example, input signals of small magnitude to be handled at increased amplification or without the risk of cutting off the signal to be employed for resetting the pulse generator. This has been accomplished by providing different levels of attenuation for the signal supplied to the input amplifier and by selecting the desired attenuation by means of a program held in a pacemaker memory store.
- an implantable cardiac pacemaker having a pacemaker function programmably alterable from a remote source of pacemaker function programming signals, comprising pulse generating means (1, 2, 3, 4,) for periodically issuing stimulating pulses, an input amplifier (12) for sensing signals at the heart and for resetting said generating means in response to a sensed signal, and memory means (18) responsive to signals from said remote source for varying the signal provided by the input amplifier for resetting said pulse generating means, characterised in that said varying means comprises a potential dividing network (11, 14) provided with an intermediate tap connected to the input of said input amplifier (12), means (13) connecting one extremity of said network to sense signals at the heart, and means (15, 16, 17) connected to apply to the other extremity of said network a potential controlled by an output signal of said memory means (18) for controlling the magnitude of the sensed heart signal applied to the input amplifier.
- the pacemaker comprises an oscillator 1 which clocks a ripple counter 2.
- Various outputs from the ripple counter are combined as is known in the art by means of logic gates (not shown) to provide four output lines 3.
- the oscillator frequency and combination of ripple counter outputs are selected so that the four output lines 3 provide, respectively, body stimulation pulses at four different frequencies (e.g. 50, 60, 70, 80 pulses per minute).
- the four output lines 3 are supplied to a rate decoder 4 provided with two input control lines 5.
- the logic levels on lines 5 can be employed to select uniquely one from four of the four lines 3 and transmit the selected pulse frequency on line 6.
- Line 6 is connected to an output amplifier 7 which in turn is connected to a connection 8 which leads to an active stimulating pulse electrode (not shown) disposed in or on the heart.
- Line 6 also provides one input to an OR gate 9.
- OR gate 9 The output of OR gate 9 is supplied to a delay unit 10 whose output is employed to reset counter 2.
- the delay generated by delay unit 10 sets the pulse width for each artificial stimulating pulse which is transmitted on output line 6.
- the active electrode disposed in or on the heart feeds back the electrical signals detected at the heart (arising from an artificial stimulating pulse or a natural heart beat) to the pacemaker via a resistor 11 (R1).
- the output of resistor R 1 is connected to an input amplifier 12 which in turn supplies a second input to OR gate 9.
- the feedback loop for such signals through the active electrode is illustrated by means of line 13.
- a second resistor 14 Connected to input amplifier 12 is a second resistor 14 (R 2 ), which is connected via a capacitor 15 to the drain of a field effect transistor 16, the source of which is connected to Vpp.
- the gate of the transistor 16 is controlled by a control line 17 which, as with control lines 5, extends from a pacemaker program store 18.
- the program store 18 is arranged to hold, as a pacemaker program, a series of binary values for supply on the control lines 5 and 17.
- a receiver/decoder 19 is arranged to receive and decode data signals transmitted from outside the patient's body to the implanted pacemaker, and to employ the decoded signals for changing a pacemaker program held in program store 18.
- the data signals may be transmitted to the receiver/decoder 19 by any suitable means, but preferably we employ data signals transmitted by tone burst modulation (pulse width modulation of a carrier frequency).
- the pacemaker operates as follows. A program is entered and held in the program store 18 and the binary levels on control lines 5 determine which one of the four outputs 3 derived from counter 2 is passed by rate decoder 4 onto output line 6.
- the counter 2 In the absence of natural heart beats, the counter 2 successively generates a series of artificial pulses at the selected rate and these are supplied to the heart via output amplifier 7. Each artificial pulse causes a reset of counter 2 via OR gate 9 and delay 10 to enable the count for the next artificial pulse to commence.
- the pacemaker operates in a normal demand mode-issuing artificial pulses only when demanded by the heart. It is of no consequence if the reset initiated by a natural heart beat arrives just as an artificial pulse is generated, since the natural beat and the stimulating pulse will essentially coincide.
- a "0" is held in the program store 18 and this causes attenuation of the input signal to amplifier 12.
- the gain of amplifier 12 and other parameters of the circuit are set such that the attenuation is acceptable and that the attenuated signal received is still of sufficient magnitude to carry out its necessary function of controlling the demand function of the pacemaker.
- the program is changed to "1", to cause R 2 to float and remove attenuation of the input signal.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Description
- This invention relates to cardiac pacemakers.
- Pacemakers for generating artificial stimulating pulses for the heart, and which may be implanted in the body, are well known. Originally the electrical circuitry for such pacemakers was of analog design, but in recent years digital circuitry has been also employed. A digital approach to pacemakers has led to the evolution of programmable pacemakers-pacemakers having parameters such as pulse rates which are adjustable (programmable) once the pacemaker has been implanted. The programs can be changed from outside the patient's body by appropriate signal transmission to the implanted pacemaker and without surgery. Programmable pacemakers are described in for instance, British Specifications 1,385,954 and 1,398,875. Such pacemakers have circuitry to detect and decode signals transmitted outside the body and alter the program accordingly. In British Specification 1,385,954 the programming is accomplished by means of a magnetic field which is sensed by a magnetic reed switch; the opening and closing of the switch providing programming pulses to a program store. In British Specification 1,398,875 the programming is by means of radio frequency transmission and reception.
- Many pacemakers are of the demand type- that is they only supply a stimulating pulse to the heart when a natural heart beat is absent. To accomplish this, demand pacemakers have means for sensing the presence or absence of natural heat beats and for actuating the stimulating pulse as appropriate.
- Demand pacemakers normally have an input amplifier which receives the electrical signals detected at the heart, and the amplified signals are then employed to control the demand function of the pacemaker. Generally, signals provided by the input amplifier are employed to inhibit any artificial pulse being generated by the pacemaker: the absence of such signals being taken by the pacemaker as indicating the absence of a normal heart beat and causing artificial stimulating pulses to be generated.
- Pacemakers are implanted in the body for a period of years, and during that time various parameters can change causing the effective signals supplied by the input amplifier to change in magnitude. Typical of such parameters is an increase in impedance of the body tissue as "seen" by the pacing electrode. But most prevalent is the wide range of electrode placement effectiveness which can result in not only very large but very small signals.
- U.S. Patent 4,049,004 describes an implantable cardiac pacemaker with a number of externally programmable pacemaker functions including the sensitivity of the pacemaker response to signals at the heart. The pacemaker includes an R-wave input amplifier constructed as an operational amplifier whose output is employed for resetting the stimulating pulse generator, thereby giving the pacemaker a demand capability. The output of the operational amplifier is supplied to a field effect transistor whose switching threshold is varied from a master parameter control. The latter is a memory store whose contents may be varied after implantation from a remote source of programming signals. This arrangement has no effect on the overall amplification provided to the signal supplied to the R-wave amplifier and can cause erroneous control of the pacemaker in certain operational states. For example, with input signals of small amplitude (and which desirably require increased amplification) and with the field effect transistor on its least sensitive setting, the signal supplied to the transistor by the R-wave amplifier will be insufficient to switch it on and thus would not reset the pulse generator as required. Under some circumstances, therefore, the field effect transistor can cut off the signal which should be employed to reset the pulse generator.
- We have now devised a pacemaker circuit which enables the signal supplied by the input amplifier to be changed after implantation and which does enable, for example, input signals of small magnitude to be handled at increased amplification or without the risk of cutting off the signal to be employed for resetting the pulse generator. This has been accomplished by providing different levels of attenuation for the signal supplied to the input amplifier and by selecting the desired attenuation by means of a program held in a pacemaker memory store.
- According to the invention there is provided an implantable cardiac pacemaker having a pacemaker function programmably alterable from a remote source of pacemaker function programming signals, comprising pulse generating means (1, 2, 3, 4,) for periodically issuing stimulating pulses, an input amplifier (12) for sensing signals at the heart and for resetting said generating means in response to a sensed signal, and memory means (18) responsive to signals from said remote source for varying the signal provided by the input amplifier for resetting said pulse generating means, characterised in that said varying means comprises a potential dividing network (11, 14) provided with an intermediate tap connected to the input of said input amplifier (12), means (13) connecting one extremity of said network to sense signals at the heart, and means (15, 16, 17) connected to apply to the other extremity of said network a potential controlled by an output signal of said memory means (18) for controlling the magnitude of the sensed heart signal applied to the input amplifier.
- Although several levels of signal level attenuation are possible (and from which selection can be made), it has been found that two levels are sufficient in practice ("high" and "low"). Appropriate selection of one of these two levels can be accomplished simply by a single binary bit held in the program store.
- Preferred features of the invention are illustrated, by way of example, in the accompanying drawing which shows schematically an electrical circuit diagram of an implantable demand cardiac pacemaker according to the invention.
- Referring to the drawing, the pacemaker comprises an oscillator 1 which clocks a ripple counter 2. Various outputs from the ripple counter are combined as is known in the art by means of logic gates (not shown) to provide four output lines 3. The oscillator frequency and combination of ripple counter outputs are selected so that the four output lines 3 provide, respectively, body stimulation pulses at four different frequencies (e.g. 50, 60, 70, 80 pulses per minute). The four output lines 3 are supplied to a rate decoder 4 provided with two input control lines 5. By employing binary logic circuitry, the logic levels on lines 5 can be employed to select uniquely one from four of the four lines 3 and transmit the selected pulse frequency on line 6. Line 6 is connected to an output amplifier 7 which in turn is connected to a connection 8 which leads to an active stimulating pulse electrode (not shown) disposed in or on the heart. Line 6 also provides one input to an
OR gate 9. - The output of
OR gate 9 is supplied to adelay unit 10 whose output is employed to reset counter 2. The delay generated bydelay unit 10 sets the pulse width for each artificial stimulating pulse which is transmitted on output line 6. - The active electrode disposed in or on the heart feeds back the electrical signals detected at the heart (arising from an artificial stimulating pulse or a natural heart beat) to the pacemaker via a resistor 11 (R1). The output of resistor R1 is connected to an
input amplifier 12 which in turn supplies a second input toOR gate 9. The feedback loop for such signals through the active electrode is illustrated by means ofline 13. - Connected to
input amplifier 12 is a second resistor 14 (R2), which is connected via acapacitor 15 to the drain of afield effect transistor 16, the source of which is connected to Vpp. The gate of thetransistor 16 is controlled by a control line 17 which, as with control lines 5, extends from apacemaker program store 18. Theprogram store 18 is arranged to hold, as a pacemaker program, a series of binary values for supply on the control lines 5 and 17. - A receiver/
decoder 19 is arranged to receive and decode data signals transmitted from outside the patient's body to the implanted pacemaker, and to employ the decoded signals for changing a pacemaker program held inprogram store 18. For the purposes of illustration, the receiver/decoder 19 andstore 18 have been depicted simply in functional box-form. The data signals may be transmitted to the receiver/decoder 19 by any suitable means, but preferably we employ data signals transmitted by tone burst modulation (pulse width modulation of a carrier frequency). - The pacemaker operates as follows. A program is entered and held in the
program store 18 and the binary levels on control lines 5 determine which one of the four outputs 3 derived from counter 2 is passed by rate decoder 4 onto output line 6. - In the absence of natural heart beats, the counter 2 successively generates a series of artificial pulses at the selected rate and these are supplied to the heart via output amplifier 7. Each artificial pulse causes a reset of counter 2 via OR
gate 9 and delay 10 to enable the count for the next artificial pulse to commence. - If a natural heart beat arises, an electrical signal is received by
input amplifier 12 and counter 2 is reset (via ORgate 9 and delay 10) to inhibit any count in the process of being generated. Thus described, the pacemaker operates in a normal demand mode-issuing artificial pulses only when demanded by the heart. It is of no consequence if the reset initiated by a natural heart beat arrives just as an artificial pulse is generated, since the natural beat and the stimulating pulse will essentially coincide. - Should it be wished to vary the overall gain of the input amplifier, then this may be accomplished as follows. If a "1" is held in
program store 18 for output on line 17 ("1"=VpD), then the gate voltage oftransistor 16 equals VDD and maintains the latter non-conducting: the point "X" betweencapacitor 15 andtransistor 16 drain "floats". In such a circumstance R2 has no influence on the magnitude of the input signal to inputamplifier 12, as applied through resistor R1. - If a "0" is held in the
program store 18 for output on line 17,transistor 16 conducts and this causes point "X" to be at VDD* The result of this is to cause R1 and R2 to act as a potential divider for the input signal, causing the input signal to the input amplifier to be attenuated. - In the normal circumstances, a "0" is held in the
program store 18 and this causes attenuation of the input signal to amplifier 12. The gain ofamplifier 12 and other parameters of the circuit are set such that the attenuation is acceptable and that the attenuated signal received is still of sufficient magnitude to carry out its necessary function of controlling the demand function of the pacemaker. - Should it be desired to increase the overall gain of the input amplifier (e.g. when there is an electrode displacement, or when the pacemaker batteries have suffered some loss of power after a relatively long period of use or when there is poor electrode placement, or the growth of tissue, all of which alter the signal "seen" by the pacemaker), then the program is changed to "1", to cause R2 to float and remove attenuation of the input signal.
- It will be appreciated that the circuit described above has been described in simple form, schematically, for the purposes of clarity. Also, though the amplifiers have been shown as single-input components it is of course possible to employ two input amplifiers (e.g. differential amplifiers).
Claims (3)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3491777 | 1977-08-19 | ||
GB3491777 | 1977-08-19 | ||
US05/917,142 US4202342A (en) | 1977-08-19 | 1978-06-19 | Programmable pacer with variable amplifier sensitivity and pacing rate |
US917142 | 1978-06-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0000984A1 EP0000984A1 (en) | 1979-03-07 |
EP0000984B1 true EP0000984B1 (en) | 1983-05-11 |
Family
ID=26262494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19780300237 Expired EP0000984B1 (en) | 1977-08-19 | 1978-08-03 | Programmable pacer with variable amplifier gain |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0000984B1 (en) |
AU (1) | AU3895778A (en) |
CA (1) | CA1098591A (en) |
DE (1) | DE2862246D1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2440199A1 (en) * | 1978-11-06 | 1980-05-30 | Medtronic Inc | ON-DEMAND CARDIAC STIMULATOR |
US5080096A (en) * | 1990-07-06 | 1992-01-14 | Medtronic, Inc. | Method and apparatus for accessing a nonvolatile memory |
EP2851048B1 (en) | 2013-09-19 | 2018-09-05 | The Procter and Gamble Company | Absorbent cores having material free areas |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3830242A (en) * | 1970-06-18 | 1974-08-20 | Medtronic Inc | Rate controller and checker for a cardiac pacer pulse generator means |
NL7700427A (en) * | 1976-03-03 | 1977-09-06 | Arco Med Prod Co | PLANTABLE DIGITAL PASSENGER WHICH IS FITTED WITH EXTERNALLY SELECTABLE BUSINESS PARAMETERS. |
-
1978
- 1978-08-03 EP EP19780300237 patent/EP0000984B1/en not_active Expired
- 1978-08-03 DE DE7878300237T patent/DE2862246D1/en not_active Expired
- 1978-08-16 AU AU38957/78A patent/AU3895778A/en active Pending
- 1978-08-17 CA CA309,563A patent/CA1098591A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU3895778A (en) | 1980-02-21 |
DE2862246D1 (en) | 1983-06-16 |
CA1098591A (en) | 1981-03-31 |
EP0000984A1 (en) | 1979-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4556063A (en) | Telemetry system for a medical device | |
US5443486A (en) | Method and apparatus to limit control of parameters of electrical tissue stimulators | |
US4606349A (en) | Implantable cardiac pacer having dual frequency programming and bipolar/unipolar lead programmability | |
EP0800414B1 (en) | Pacemaker with a modified tachycardia detection based on ffrw sensing | |
AU596933B2 (en) | Oxygen sensing pacemaker | |
US5360437A (en) | Implantable medical device with flexible hardware platform | |
US4181133A (en) | Programmable tachycardia pacer | |
US5016634A (en) | Implantable medical device with means for telemetric transmission of data | |
US5243979A (en) | Method and apparatus for implementing activity sensing in a pulse generator | |
EP0349130B1 (en) | Implantable cardiac stimulator with automatic gain control | |
US5441525A (en) | Pacemaker with vasovagal syncope detection | |
EP0559193B1 (en) | Implantable pacemaker providing hysteresis in dual-chamber modes | |
US8639337B2 (en) | Pacemaker passive measurement testing system | |
US4561444A (en) | Implantable cardiac pacer having dual frequency programming and bipolar/linipolar lead programmability | |
SE451670B (en) | HEART STIMULATOR WITH PREVIOUS CONTROL FUNCTION | |
ES456504A1 (en) | Implantable digital cardiac pacer having externally selectible operaing parameters | |
EP0709114B1 (en) | Dual chamber pacemaker system with improved switching between synchronous and asynchronous behavior | |
US4202342A (en) | Programmable pacer with variable amplifier sensitivity and pacing rate | |
EP0000984B1 (en) | Programmable pacer with variable amplifier gain | |
EP0879619B1 (en) | Pacemaker system with special function rate response | |
US4203448A (en) | Programmably variable voltage multiplier for implanted stimulator | |
JPH0344785B2 (en) | ||
US4304237A (en) | Dual mode programmable pacer | |
US4169480A (en) | Demand pacer with programmable rate hysteresis | |
EP0000987A1 (en) | Demand pacer with programmable rate hysteresis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): DE FR GB NL SE |
|
17P | Request for examination filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): DE FR GB NL SE |
|
REF | Corresponds to: |
Ref document number: 2862246 Country of ref document: DE Date of ref document: 19830616 |
|
ET | Fr: translation filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19830731 Year of fee payment: 6 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19840804 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19840828 Year of fee payment: 7 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19860831 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19880301 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19880429 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19881117 |
|
EUG | Se: european patent has lapsed |
Ref document number: 78300237.1 Effective date: 19850612 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19971028 Year of fee payment: 20 |